
Dr James Murray
Photo Credit: Courtesy of Swansea University
Scientific Frontline: Extended "At a Glance" Summary: Microglia and Neuronal Stability in Alzheimer's Disease
The Core Concept: Microglia, the primary immune cells of the brain, play a critical protective role in maintaining the stability of neuronal networks, challenging the traditional view that they act solely as drivers of neuroinflammation in Alzheimer's disease.
Key Distinction/Mechanism: While current experimental Alzheimer's treatments frequently attempt to reduce microglial numbers or activity by blocking the colony stimulating factor 1 receptor (CSF1R), this indiscriminate suppression increases abnormal, epilepsy-like electrical hyperexcitability in the brain and fails to improve memory.
Major Frameworks/Components:
- Microglia: The resident macrophage cells of the central nervous system that perform vital neuroprotective "housekeeping" tasks alongside their inflammatory responses.
- CSF1R Inhibition: The pharmacological targeting of the CSF1R receptor (using the drug GW2580) to deplete microglial populations.
- Network Hyperexcitability: The destabilization of brain electrical activity, leading to epilepsy-like events, which occurs when protective immune cells are removed.
- APP/PS1 Mouse Model: A well-established transgenic animal model used to study the pathological progression of Alzheimer's disease in vivo.

.jpg)




.png)
.jpg)
.jpg)




